Michael D. Nyquist

1.9k total citations
14 papers, 755 citations indexed

About

Michael D. Nyquist is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Michael D. Nyquist has authored 14 papers receiving a total of 755 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 8 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Michael D. Nyquist's work include Prostate Cancer Treatment and Research (11 papers), Hormonal and reproductive studies (4 papers) and Protein Degradation and Inhibitors (4 papers). Michael D. Nyquist is often cited by papers focused on Prostate Cancer Treatment and Research (11 papers), Hormonal and reproductive studies (4 papers) and Protein Degradation and Inhibitors (4 papers). Michael D. Nyquist collaborates with scholars based in United States, Australia and Egypt. Michael D. Nyquist's co-authors include Scott M. Dehm, Daniel F. Voytas, Elahe A. Mostaghel, Peter S. Nelson, Yingming Li, Eva Corey, Robert L. Vessella, Tae Hyun Hwang, Jared M. Lucas and Kevin A.T. Silverstein and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Clinical Investigation.

In The Last Decade

Michael D. Nyquist

14 papers receiving 751 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael D. Nyquist United States 11 467 434 189 135 111 14 755
N. Sarath Krishna United Kingdom 7 451 1.0× 368 0.8× 189 1.0× 115 0.9× 142 1.3× 11 691
Anthony J. Saporita United States 11 188 0.4× 523 1.2× 137 0.7× 176 1.3× 134 1.2× 16 781
Sen Pathak United States 7 254 0.5× 315 0.7× 116 0.6× 143 1.1× 97 0.9× 12 558
Suzan Stelloo Netherlands 13 297 0.6× 389 0.9× 148 0.8× 141 1.0× 106 1.0× 23 603
Myles C. Hodgson United States 11 214 0.5× 357 0.8× 116 0.6× 88 0.7× 132 1.2× 14 565
Cheng-Lung Hsu Taiwan 12 323 0.7× 411 0.9× 130 0.7× 111 0.8× 275 2.5× 15 759
Hetty A. van der Korput Netherlands 6 261 0.6× 288 0.7× 84 0.4× 66 0.5× 78 0.7× 6 430
Sepideh Vahid Canada 8 271 0.6× 287 0.7× 100 0.5× 125 0.9× 45 0.4× 16 470
Benjamin Sunkel United States 9 216 0.5× 295 0.7× 105 0.6× 82 0.6× 96 0.9× 11 462
William E. Bingman United States 10 360 0.8× 412 0.9× 137 0.7× 62 0.5× 325 2.9× 11 710

Countries citing papers authored by Michael D. Nyquist

Since Specialization
Citations

This map shows the geographic impact of Michael D. Nyquist's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael D. Nyquist with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael D. Nyquist more than expected).

Fields of papers citing papers by Michael D. Nyquist

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael D. Nyquist. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael D. Nyquist. The network helps show where Michael D. Nyquist may publish in the future.

Co-authorship network of co-authors of Michael D. Nyquist

This figure shows the co-authorship network connecting the top 25 collaborators of Michael D. Nyquist. A scholar is included among the top collaborators of Michael D. Nyquist based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael D. Nyquist. Michael D. Nyquist is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Nyquist, Michael D., Ilsa M. Coleman, Jared M. Lucas, et al.. (2023). Supraphysiological Androgens Promote the Tumor Suppressive Activity of the Androgen Receptor through cMYC Repression and Recruitment of the DREAM Complex. Cancer Research. 83(17). 2938–2951. 6 indexed citations
2.
Nyquist, Michael D., Alexandra Corella, Ilsa M. Coleman, et al.. (2020). Combined TP53 and RB1 Loss Promotes Prostate Cancer Resistance to a Spectrum of Therapeutics and Confers Vulnerability to Replication Stress. Cell Reports. 31(8). 107669–107669. 163 indexed citations
3.
Chatterjee, Payel, Michael T. Schweizer, Jared M. Lucas, et al.. (2019). Supraphysiological androgens suppress prostate cancer growth through androgen receptor–mediated DNA damage. Journal of Clinical Investigation. 129(10). 4245–4260. 67 indexed citations
4.
Nyquist, Michael D., Alexandra Corella, Ilsa M. Coleman, et al.. (2019). Molecular determinants of response to high-dose androgen therapy in prostate cancer. JCI Insight. 4(19). 18 indexed citations
5.
Sinha, Seema, Michael D. Nyquist, Alexandra Corella, Ilsa M. Coleman, & Peter S. Nelson. (2018). Abstract LB-199: Role of ASCL1 in neuroendocrine prostate cancer progression. Cancer Research. 78(13_Supplement). LB–199. 2 indexed citations
6.
Nyquist, Michael D., Alexandra Corella, Ilsa M. Coleman, et al.. (2017). Exploiting AR-Regulated Drug Transport to Induce Sensitivity to the Survivin Inhibitor YM155. Molecular Cancer Research. 15(5). 521–531. 15 indexed citations
7.
Etten, Jamie L. Van, Michael D. Nyquist, Yingming Li, et al.. (2017). Targeting a Single Alternative Polyadenylation Site Coordinately Blocks Expression of Androgen Receptor mRNA Splice Variants in Prostate Cancer. Cancer Research. 77(19). 5228–5235. 51 indexed citations
8.
Nyquist, Michael D., Alexandra Corella, Ilsa M. Coleman, et al.. (2017). Exploiting AR-Regulated Drug Transport to Induce Sensitivity to the Survivin Inhibitor YM155. Molecular Cancer Research. 15(5). 521–531. 2 indexed citations
9.
Nyquist, Michael D., Michael T. Schweizer, Stephen Balk, et al.. (2017). Supraphysiologic Testosterone Therapy in the Treatment of Prostate Cancer: Models, Mechanisms and Questions. Cancers. 9(12). 166–166. 32 indexed citations
10.
Nyquist, Michael D., Bhagwat Prasad, & Elahe A. Mostaghel. (2017). Harnessing Solute Carrier Transporters for Precision Oncology. Molecules. 22(4). 539–539. 34 indexed citations
11.
Chan, Siu Chiu, Luke A. Selth, Yingming Li, et al.. (2015). Targeting chromatin binding regulation of constitutively active AR variants to overcome prostate cancer resistance to endocrine-based therapies. Nucleic Acids Research. 43(12). 5880–5897. 119 indexed citations
12.
Nyquist, Michael D. & Scott M. Dehm. (2013). Interplay Between Genomic Alterations and Androgen Receptor Signaling During Prostate Cancer Development and Progression. Hormones and Cancer. 4(2). 61–69. 32 indexed citations
13.
Nyquist, Michael D., Yingming Li, Tae Hyun Hwang, et al.. (2013). TALEN-engineered AR gene rearrangements reveal endocrine uncoupling of androgen receptor in prostate cancer. Proceedings of the National Academy of Sciences. 110(43). 17492–17497. 126 indexed citations
14.
Christian, Michelle, Zachary L. Demorest, Colby G. Starker, et al.. (2012). Targeting G with TAL Effectors: A Comparison of Activities of TALENs Constructed with NN and NK Repeat Variable Di-Residues. PLoS ONE. 7(9). e45383–e45383. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026